In conclusion, in this study, we found a high prevalence of increased Lp(a) levels and, as expected, strong associations with CAD in patients with hyperlipidemias, which indicates the need for efficient lowering of Lp(a) levels to decrease coronary risk. The gene discussed is LPA; the disease is hyperlipidemia.